nodes	percent_of_prediction	percent_of_DWPC	metapath
Clozapine—ABCB1—peripheral nervous system neoplasm	0.23	1	CbGaD
Clozapine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0674	0.12	CbGbCtD
Clozapine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0576	0.103	CbGbCtD
Clozapine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0496	0.0883	CbGbCtD
Clozapine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0383	0.0682	CbGbCtD
Clozapine—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0377	0.0671	CbGbCtD
Clozapine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0333	0.0593	CbGbCtD
Clozapine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0277	0.0493	CbGbCtD
Clozapine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0242	0.0431	CbGbCtD
Clozapine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0242	0.0431	CbGbCtD
Clozapine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0232	0.0413	CbGbCtD
Clozapine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0221	0.0394	CbGbCtD
Clozapine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0187	0.0334	CbGbCtD
Clozapine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0168	0.0299	CbGbCtD
Clozapine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0145	0.0258	CbGbCtD
Clozapine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.014	0.0249	CbGbCtD
Clozapine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0135	0.024	CbGbCtD
Clozapine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0108	0.0193	CbGbCtD
Clozapine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0103	0.0184	CbGbCtD
Clozapine—HTR1D—meninx—peripheral nervous system neoplasm	0.0102	0.0868	CbGeAlD
Clozapine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00993	0.0177	CbGbCtD
Clozapine—HTR1B—dura mater—peripheral nervous system neoplasm	0.0097	0.0825	CbGeAlD
Clozapine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00964	0.0172	CbGbCtD
Clozapine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00947	0.0169	CbGbCtD
Clozapine—HTR1D—dura mater—peripheral nervous system neoplasm	0.00939	0.0799	CbGeAlD
Clozapine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00646	0.0115	CbGbCtD
Clozapine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00619	0.011	CbGbCtD
Clozapine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00609	0.0108	CbGbCtD
Clozapine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00567	0.0101	CbGbCtD
Clozapine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00549	0.0467	CbGeAlD
Clozapine—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.00465	0.0396	CbGeAlD
Clozapine—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00417	0.0355	CbGeAlD
Clozapine—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00404	0.0344	CbGeAlD
Clozapine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00387	0.0069	CbGbCtD
Clozapine—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00354	0.0301	CbGeAlD
Clozapine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00301	0.0256	CbGeAlD
Clozapine—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00297	0.0253	CbGeAlD
Clozapine—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00288	0.0245	CbGeAlD
Clozapine—HTR6—ganglion—peripheral nervous system neoplasm	0.0025	0.0212	CbGeAlD
Clozapine—CALY—trigeminal ganglion—peripheral nervous system neoplasm	0.00236	0.0201	CbGeAlD
Clozapine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00229	0.0195	CbGeAlD
Clozapine—HTR7—pons—peripheral nervous system neoplasm	0.00226	0.0193	CbGeAlD
Clozapine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00201	0.0171	CbGeAlD
Clozapine—DRD1—nerve—peripheral nervous system neoplasm	0.00188	0.016	CbGeAlD
Clozapine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00188	0.016	CbGeAlD
Clozapine—DRD1—ganglion—peripheral nervous system neoplasm	0.00186	0.0158	CbGeAlD
Clozapine—HTR3A—nerve—peripheral nervous system neoplasm	0.00182	0.0154	CbGeAlD
Clozapine—HTR3A—ganglion—peripheral nervous system neoplasm	0.00179	0.0153	CbGeAlD
Clozapine—HRH3—brainstem—peripheral nervous system neoplasm	0.00163	0.0138	CbGeAlD
Clozapine—HTR1B—ganglion—peripheral nervous system neoplasm	0.0015	0.0128	CbGeAlD
Clozapine—HTR1D—ganglion—peripheral nervous system neoplasm	0.00146	0.0124	CbGeAlD
Clozapine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00144	0.0123	CbGeAlD
Clozapine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00143	0.0122	CbGeAlD
Clozapine—HTR2A—pons—peripheral nervous system neoplasm	0.00141	0.012	CbGeAlD
Clozapine—HTR1E—brainstem—peripheral nervous system neoplasm	0.00138	0.0118	CbGeAlD
Clozapine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00121	0.0103	CbGeAlD
Clozapine—FMO3—parotid gland—peripheral nervous system neoplasm	0.00119	0.0101	CbGeAlD
Clozapine—HTR7—nerve—peripheral nervous system neoplasm	0.00117	0.00999	CbGeAlD
Clozapine—HTR7—ganglion—peripheral nervous system neoplasm	0.00116	0.00987	CbGeAlD
Clozapine—DRD2—nerve—peripheral nervous system neoplasm	0.00111	0.00945	CbGeAlD
Clozapine—DRD2—ganglion—peripheral nervous system neoplasm	0.0011	0.00933	CbGeAlD
Clozapine—CALY—cerebellum—peripheral nervous system neoplasm	0.00103	0.00875	CbGeAlD
Clozapine—H1F0—trigeminal ganglion—peripheral nervous system neoplasm	0.000923	0.00786	CbGeAlD
Clozapine—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.000881	0.00749	CbGeAlD
Clozapine—H1F0—parotid gland—peripheral nervous system neoplasm	0.000871	0.00741	CbGeAlD
Clozapine—DRD1—brainstem—peripheral nervous system neoplasm	0.000807	0.00686	CbGeAlD
Clozapine—HRH3—cerebellum—peripheral nervous system neoplasm	0.000802	0.00682	CbGeAlD
Clozapine—HTR3A—brainstem—peripheral nervous system neoplasm	0.000779	0.00663	CbGeAlD
Clozapine—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.000739	0.00628	CbGeAlD
Clozapine—HTR2A—nerve—peripheral nervous system neoplasm	0.000733	0.00623	CbGeAlD
Clozapine—HTR2A—ganglion—peripheral nervous system neoplasm	0.000723	0.00615	CbGeAlD
Clozapine—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.000715	0.00608	CbGeAlD
Clozapine—HTR1B—brainstem—peripheral nervous system neoplasm	0.000654	0.00556	CbGeAlD
Clozapine—HTR1D—brainstem—peripheral nervous system neoplasm	0.000633	0.00538	CbGeAlD
Clozapine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000631	0.00537	CbGeAlD
Clozapine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000627	0.00533	CbGeAlD
Clozapine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000528	0.00449	CbGeAlD
Clozapine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.000524	0.00446	CbGeAlD
Clozapine—HTR7—brainstem—peripheral nervous system neoplasm	0.000504	0.00429	CbGeAlD
Clozapine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000494	0.0042	CbGeAlD
Clozapine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000486	0.00414	CbGeAlD
Clozapine—DRD2—brainstem—peripheral nervous system neoplasm	0.000477	0.00406	CbGeAlD
Clozapine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000425	0.00362	CbGeAlD
Clozapine—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000423	0.0036	CbGeAlD
Clozapine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000418	0.00355	CbGeAlD
Clozapine—H1F0—cerebellum—peripheral nervous system neoplasm	0.000403	0.00343	CbGeAlD
Clozapine—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.000377	0.00321	CbGeAlD
Clozapine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000314	0.00267	CbGeAlD
Clozapine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000286	0.00244	CbGeAlD
Clozapine—CYP1B1—cerebellum—peripheral nervous system neoplasm	0.000277	0.00235	CbGeAlD
Clozapine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00026	0.00221	CbGeAlD
Clozapine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000249	0.00211	CbGeAlD
Clozapine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.00024	0.00204	CbGeAlD
Clozapine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000235	0.002	CbGeAlD
Clozapine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000233	0.00198	CbGeAlD
Clozapine—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000229	0.00194	CbGeAlD
Clozapine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000182	0.00155	CbGeAlD
Clozapine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000178	0.00152	CbGeAlD
Clozapine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000155	0.00132	CbGeAlD
Clozapine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000141	0.0012	CbGeAlD
Clozapine—Azelastine—ABCB1—peripheral nervous system neoplasm	0.000137	0.201	CrCbGaD
Clozapine—Olanzapine—ABCB1—peripheral nervous system neoplasm	0.000118	0.173	CrCbGaD
Clozapine—Trazodone—ABCB1—peripheral nervous system neoplasm	0.000114	0.167	CrCbGaD
Clozapine—Clobazam—ABCB1—peripheral nervous system neoplasm	0.000107	0.156	CrCbGaD
Clozapine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000102	0.000864	CbGeAlD
Clozapine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	7.38e-05	0.108	CrCbGaD
Clozapine—Quetiapine—ABCB1—peripheral nervous system neoplasm	7.16e-05	0.105	CrCbGaD
Clozapine—Diazepam—ABCB1—peripheral nervous system neoplasm	6.23e-05	0.0912	CrCbGaD
Clozapine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	8.1e-06	8.92e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.06e-06	8.87e-05	CbGpPWpGaD
Clozapine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.06e-06	8.87e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.99e-06	8.8e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.98e-06	8.79e-05	CbGpPWpGaD
Clozapine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.95e-06	8.75e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.92e-06	8.72e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	7.88e-06	8.67e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.88e-06	8.67e-05	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.84e-06	8.63e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.83e-06	8.62e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.81e-06	8.6e-05	CbGpPWpGaD
Clozapine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	7.76e-06	8.54e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.7e-06	8.48e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.65e-06	8.43e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.65e-06	8.42e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.64e-06	8.41e-05	CbGpPWpGaD
Clozapine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.61e-06	8.38e-05	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.6e-06	8.37e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.59e-06	8.36e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	7.59e-06	8.36e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.58e-06	8.34e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.56e-06	8.33e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.56e-06	8.32e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.54e-06	8.3e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.53e-06	8.29e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	7.53e-06	8.29e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.51e-06	8.27e-05	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.49e-06	8.25e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.46e-06	8.21e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.45e-06	8.2e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.44e-06	8.19e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.44e-06	8.19e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.44e-06	8.19e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.43e-06	8.18e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.42e-06	8.17e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.4e-06	8.15e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	7.39e-06	8.13e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.38e-06	8.12e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.36e-06	8.1e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.32e-06	8.05e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.31e-06	8.04e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.29e-06	8.02e-05	CbGpPWpGaD
Clozapine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.25e-06	7.98e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.22e-06	7.95e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.19e-06	7.91e-05	CbGpPWpGaD
Clozapine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.16e-06	7.88e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.09e-06	7.81e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.05e-06	7.76e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7e-06	7.7e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.99e-06	7.69e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.94e-06	7.64e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.91e-06	7.61e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.89e-06	7.59e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.81e-06	7.5e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.8e-06	7.49e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.77e-06	7.46e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.77e-06	7.45e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.69e-06	7.37e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.65e-06	7.32e-05	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.62e-06	7.28e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.6e-06	7.27e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.59e-06	7.25e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.59e-06	7.25e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.52e-06	7.18e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.51e-06	7.17e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.5e-06	7.15e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.48e-06	7.14e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.47e-06	7.12e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.47e-06	7.12e-05	CbGpPWpGaD
Clozapine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.46e-06	7.11e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.43e-06	7.08e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.42e-06	7.06e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.4e-06	7.05e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.38e-06	7.03e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.33e-06	6.97e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.32e-06	6.96e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.31e-06	6.95e-05	CbGpPWpGaD
Clozapine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.24e-06	6.87e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.23e-06	6.86e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.21e-06	6.83e-05	CbGpPWpGaD
Clozapine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.21e-06	6.83e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.18e-06	6.8e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.17e-06	6.79e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.15e-06	6.77e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.15e-06	6.77e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.11e-06	6.73e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.08e-06	6.69e-05	CbGpPWpGaD
Clozapine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.04e-06	6.64e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.02e-06	6.63e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.98e-06	6.58e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.98e-06	6.58e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.94e-06	6.54e-05	CbGpPWpGaD
Clozapine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.94e-06	6.54e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.89e-06	6.48e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.89e-06	6.48e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.88e-06	6.48e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.87e-06	6.46e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.87e-06	6.46e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.85e-06	6.44e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.83e-06	6.42e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.78e-06	6.36e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.76e-06	6.34e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.66e-06	6.24e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.64e-06	6.2e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.63e-06	6.2e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.61e-06	6.18e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.54e-06	6.1e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.54e-06	6.09e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.53e-06	6.09e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.51e-06	6.07e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.49e-06	6.05e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.48e-06	6.03e-05	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.48e-06	6.03e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.44e-06	5.99e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.43e-06	5.97e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.43e-06	5.97e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.39e-06	5.94e-05	CbGpPWpGaD
Clozapine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.39e-06	5.93e-05	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.38e-06	5.92e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.37e-06	5.91e-05	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.36e-06	5.9e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.35e-06	5.89e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.35e-06	5.89e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.35e-06	5.89e-05	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.34e-06	5.88e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.34e-06	5.88e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.33e-06	5.86e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.31e-06	5.85e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.31e-06	5.85e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.29e-06	5.83e-05	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.29e-06	5.82e-05	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.28e-06	5.81e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.24e-06	5.77e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.23e-06	5.75e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.2e-06	5.73e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.18e-06	5.7e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.15e-06	5.67e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.12e-06	5.64e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.12e-06	5.63e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.11e-06	5.63e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.08e-06	5.59e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.05e-06	5.56e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.04e-06	5.55e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.01e-06	5.52e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5e-06	5.5e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.97e-06	5.48e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.97e-06	5.47e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.96e-06	5.46e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.93e-06	5.43e-05	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.9e-06	5.4e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.9e-06	5.39e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.89e-06	5.39e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.88e-06	5.38e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.87e-06	5.36e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.87e-06	5.36e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.86e-06	5.35e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.85e-06	5.34e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.84e-06	5.32e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.83e-06	5.32e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.83e-06	5.31e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.8e-06	5.29e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.8e-06	5.28e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.79e-06	5.27e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.67e-06	5.14e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.62e-06	5.09e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.61e-06	5.07e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.6e-06	5.06e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.55e-06	5.01e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.55e-06	5.01e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.52e-06	4.98e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.52e-06	4.97e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.49e-06	4.94e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.48e-06	4.93e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.47e-06	4.92e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.45e-06	4.9e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.45e-06	4.9e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.44e-06	4.88e-05	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	4.42e-06	4.87e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.41e-06	4.85e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.39e-06	4.84e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.39e-06	4.84e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.38e-06	4.82e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.35e-06	4.79e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.32e-06	4.76e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.26e-06	4.69e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.24e-06	4.66e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.17e-06	4.59e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.16e-06	4.58e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.15e-06	4.56e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.13e-06	4.55e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.1e-06	4.52e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.09e-06	4.51e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.08e-06	4.5e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.08e-06	4.49e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.07e-06	4.48e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.96e-06	4.36e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.94e-06	4.34e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.93e-06	4.32e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.89e-06	4.28e-05	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	3.87e-06	4.26e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.84e-06	4.23e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.83e-06	4.22e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.79e-06	4.17e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.79e-06	4.17e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.77e-06	4.15e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.77e-06	4.15e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.67e-06	4.04e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	3.65e-06	4.02e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.61e-06	3.97e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.48e-06	3.83e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.47e-06	3.82e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.43e-06	3.77e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.42e-06	3.77e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.42e-06	3.76e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.4e-06	3.75e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.39e-06	3.74e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.36e-06	3.7e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.35e-06	3.69e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.35e-06	3.68e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.33e-06	3.66e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.33e-06	3.66e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.27e-06	3.6e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.27e-06	3.6e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.26e-06	3.58e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.25e-06	3.57e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.24e-06	3.56e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.21e-06	3.54e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.21e-06	3.53e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.19e-06	3.51e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-06	3.46e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.11e-06	3.43e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.98e-06	3.28e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.94e-06	3.23e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.89e-06	3.18e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.89e-06	3.18e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.88e-06	3.18e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.88e-06	3.17e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.87e-06	3.16e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.84e-06	3.12e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.83e-06	3.12e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.72e-06	3e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.63e-06	2.9e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.5e-06	2.75e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.23e-06	2.45e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.17e-06	2.39e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.05e-06	2.26e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-06	2.24e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.74e-06	1.91e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.34e-06	1.48e-05	CbGpPWpGaD
